NRx Pharmaceuticals nears final FDA approval for preservative-free ketamine
NRx Pharmaceuticals (NASDAQ:NRXP) moved a step closer to commercializing its generic preservative-free ketamine today, announcing that the FDA’s Office of Generic Drugs has provided preliminary alignment on the product's labeling.







-640x360.webp&w=3840&q=75)















